Daniele Noviello

15PUBLICATIONS
82CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityNutritional epidemiologyEuropean Union lawCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 28, 2026
VSL#3® May Reduce Abdominal Pain and Bloating in Ulcerative Colitis Remission with IBS-like Symptoms: An Exploratory Randomized, Double-Blind Placebo-Controlled Trial.

|May 13, 2026
The Assessment of Multidimensional Clinical, Biological and Patient-Reported Outcomes to Evaluate the Efficacy of Add-On Lactobacillus rhamnosus GG Supplementation in Mild Ulcerative Colitis: A Randomized Pilot Trial.

|Apr 01, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study.

Daniele Noviello, María Chaparro, Chiara Viganò

|Jul 29, 2024
AIEC-dependent pathogenic Th17 cell transdifferentiation in Crohn's disease is suppressed by rfaP and ybaT deletion.

G Leccese, M Chiara, I Dusetti

|Feb 29, 2024
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study.

Mariangela Allocca, Gaia Catalano, Edoardo V Savarino

|Feb 02, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.

Gabriele Dragoni, Tommaso Innocenti, Aurelién Amiot

Pageof 3

Frequent Collaborators

6 joint publications

Flavio Caprioli

3 joint publications

María Chaparro

3 joint publications

Maurizio Vecchi

3 joint publications

Federica Facciotti